Back to Results

A Phase 4 Study of Nusinersen (BIIB058) Among Patients With Spinal Muscular Atrophy Who Received Onasemnogene Abeparvovec

Study

Is this Study for You?

Let's Get Started!

Details
Age

Child

Phase

IV - Research Studies occurring after FDA has approved a drug for marketing. These studies gather additional information about a drug's safety, efficacy, or optimal use.

Type of Study

Treatment

Location

Childrens Hospital Colorado

Principal Investigator
Julie Parsons

Julie Parsons

Study ID

Protocol Number: 20-2793

More information available at ClinicalTrials.gov: NCT04488133

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers